Since the free Ca2+ ion level is an important modulator of actin cytoskeletal dynamics, the goal of the present study was to investigate whether PMCA4b, by controlling intracellular Ca2+ levels, acts through the actin cytoskeleton in reducing motility of BRAF mutant melanoma cells. This evidence concerns the gene ATP2B4 and melanoma.